Abstract
Objectives: We reviewed our experience of mitral valve replacement (MVR) after percutaneous transluminal mitral commissurotomy (PTMC) for mitral stenosis (MS). Methods: From December 1987 to December 2001, PTMC was conducted in 75 patients with symptomatic rheumatic MS. At mean follow-up of 8.4±3.5 years, 11 patients (14.7%) underwent MVR for mitral restenosis (9 cases) and mitral regurgitation (MR) (2 cases). The mean interval between PTMC and MVR was 5.2±3.2 years. Results: There were 2 hospital deaths (due to low output syndrome and mediastinitis) and 2 complications (prosthetic valve endocarditis and left ventricular rupture). The mitral valve area (MVA) at pre-PTMC, post-PTMC and pre-MVR was 1.02±0.48 cm2,1.55±0.59 cm2,1.04±0.23 cm2, respectively. The MVA significantly increased after PTMC (p<0.01), but decreased significantly to the pre-PTMC value at pre-MVR (p<0.05). The left atrial dimension (LAD) significantly increased from 50.4±10.8 mm at pre-PTMC to 61.1±13.1 mm at pre-MVR (p<0.05). The number of significant tricuspid regurgitation (TR) cases increased from 2 at pre-PTMC to 5 at pre-MVR. The New York Heart Association class got better after PTMC (3 cases in class HI at pre-PTMC to 0 at post-PTMC), but at pre-MVR, deteriorated to the same level at pre-PTMC (4 cases in class III). Conclusions: Our results of MVR after PTMC were reasonable to be considered despite their high risk at MVR resulting in 2 hospital deaths. For the reliable relief of MS and control of TR, not PTMC but MVR combined with tricuspid annuloplasty may be preferable in such two cases suffering from congestive heart failure with significant TR at first intervention. Close follow-ups like periodic ultrasonic cardiography studies should be conducted to gain more information on the mitral restenosis, TR deterioration and dilatation of the cardiac chambers.
Similar content being viewed by others
References
Hamasaki N, Nosaka H, Kimura T, Nakagawa Y, Yokoi H, Iwabuchi M, et al. Ten- years clinical follow-up following successful percutaneous transvenous mitral commissurotomy: Single-center experience. Catheter Cardiovasc Interv 2000; 49: 284–8.
Harrison JK, Wilson JS, Hearne SE, Bashore TM. Complications related to percutaneous transvenous mitral commissurotomy. Cathet Cardiovasc Diagn 1994; Suppl 2: 52–60.
Saeki F, Ishizaka Y, Tamura T. Long-term clinical and echocardiographic outcome in patients with mitral stenosis treated with percutaneous transvenous mitral commissurotomy. Jpn Circ J 1999; 63: 597–604.
Abe T, Mawatari T, Takahashi N, Sakata J, Urita R, Komatsu S. Mitral valve operation after percutaneous transvenous mitral commissurotomy (PTMC): An evaluation of PTMC indications based on intraopera-tive findings. Surg Today 1996; 26: 904–9.
Palacios IF, Tuzcu ME, Weyman AE, Newell JB, Block PC. Clinical follow-up of patients undergoing percutaneous mitral balloon valvotomy. Circulation 1995; 91: 671–6.
Kosakai Y, Kawaguchi AT, Isobe F, Sasako Y, Nakano K, Eishi K, et al. Cox maze procedure for chronic atrial fibrillation associate with mitral valve., disease. J Thorac Cardiovasc Surg 1994; 108: 1049–55.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kamada, M., Ohsaka, K., Nagamine, S. et al. Mitral valve replacement after percutaneous transluminal mitral commissurotomy. Jpn J Thorac Caridovasc Surg 52, 335–338 (2004). https://doi.org/10.1007/s11748-004-0065-4
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s11748-004-0065-4